Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis
Autor: | Maria-Eleni Androutsou, Theodore Tselios, Simona Golic Grdadolnik, Lesley Probert, Areti Gkika, Agathi Nteli, Anastasia Dagkonaki, Maria Avloniti |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
asparagine deamidation experimental autoimmune encephalomyelitis Peptide multiple sclerosis Epitope Mannans lcsh:Chemistry Mice 0302 clinical medicine immune system diseases Asparagine Deamidation lcsh:QH301-705.5 Spectroscopy Mannan chemistry.chemical_classification biology Experimental autoimmune encephalomyelitis hemic and immune systems General Medicine Computer Science Applications Biochemistry Deamination 030220 oncology & carcinogenesis myelin oligodentrocyte glycoprotein Female Immunotherapy Encephalomyelitis Autoimmune Experimental Catalysis Article Myelin oligodendrocyte glycoprotein Inorganic Chemistry 03 medical and health sciences medicine Animals Physical and Theoretical Chemistry Molecular Biology Organic Chemistry Wild type medicine.disease Peptide Fragments Rats nervous system diseases carbohydrates (lipids) Mice Inbred C57BL nuclear magnetic resonance 030104 developmental biology chemistry nervous system lcsh:Biology (General) lcsh:QD1-999 biology.protein Myelin-Oligodendrocyte Glycoprotein |
Zdroj: | International Journal of Molecular Sciences, Vol 21, Iss 7566, p 7566 (2020) International Journal of Molecular Sciences Volume 21 Issue 20 |
ISSN: | 1661-6596 1422-0067 |
Popis: | Mannan (polysaccharide) conjugated with a myelin oligodendrocyte glycoprotein (MOG) peptide, namely (KG)5MOG35&ndash 55, represents a potent and promising new approach for the immunotherapy of Multiple Sclerosis (MS). The MOG35&ndash 55 epitope conjugated with the oxidized form of mannan (poly-mannose) via a (KG)5 linker was found to inhibit the symptoms of MOG35&ndash 55-induced experimental autoimmune encephalomyelitis (EAE) in mice using prophylactic and therapeutic vaccinated protocols. Deamidation is a common modification in peptide and protein sequences, especially for Gln and Asn residues. In this study, the structural solution motif of deaminated peptides and their functional effects in an animal model for MS were explored. Several peptides based on the MOG35&ndash 55 epitope have been synthesized in which the Asn53 was replaced with Ala, Asp, or isoAsp. Our results demonstrate that the synthesized MOG peptides were formed to the deaminated products in basic conditions, and the Asn53 was mainly modified to Asp. Moreover, both peptides (wild type and deaminated derivative) conjugated with mannan (from Saccharomyces cerevisiae) independently inhibited the development of neurological symptoms and inflammatory demyelinating spinal cord lesions in MOG35&ndash 55-induced EAE. To conclude, mannan conjugated with a deamidated product did not affect the efficacy of the parent peptide. |
Databáze: | OpenAIRE |
Externí odkaz: |